Company profile: Jungla
1.1 - Company Overview
Company description
- Provider of biotechnology solutions for clinical genetic and genomic testing, combining functional genomics, computational biophysics, and computer science. Offers the Molecular Evidence Platform, an active learning engine that integrates clinical knowledge to generate, evaluate, audit, and distribute evidence models, and solutions that augment and optimize clinical genetic and genomic test guidance.
Products and services
- Clinical Genetic and Genomic Test Guidance: Computationally-integrated guidance that augments and optimizes clinical genetic and genomic tests by integrating functional genomics, computational biophysics, and computer science to inform variant risk and test decision-making
- Molecular Evidence Platform (MEP): Active-learning-driven engine integrating clinical knowledge to generate, evaluate, audit, and distribute evidence models for clinical genetic and genomic tests to inform variant risk
- Clinical Genetic and Genomic Testing Results Delivery: Scalable results delivery that produces robust outcomes for clinical genetic and genomic testing by developing and combining advances in functional genomics, computational biophysics, and computer science to assess variant risk
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Jungla
CLC Bio
HQ: Denmark
Website
- Description: Provider of bioinformatics solutions focused on analyzing data from all major high-throughput sequencing machines, including instruments from Illumina, Applied Biosystems (LIFE Technologies), Roche 454, Helicos, and Sanger.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CLC Bio company profile →
Dotmatics
HQ: United States
Website
- Description: Provider of an enterprise R&D scientific software platform connecting science, data, and decision-making, with applications including electronic laboratory notebook (Dotmatics ELN), Luma AI-native multimodal scientific intelligence, scientific search, small molecule drug discovery solution, and visualization & analytics to streamline research workflows and accelerate innovation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dotmatics company profile →
Ascend Clinical
HQ: United States
Website
- Description: Provider of diagnostic laboratory testing and electronic information delivery for independent dialysis providers, offering a comprehensive testing menu, automated calculations, and specific reference ranges for results and reports to support accurate results and patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ascend Clinical company profile →
Overwatch Research
HQ: United Kingdom
Website
- Description: Provider of all-in-one experimental tracking software for in vivo research, including Benchling In Vivo for study design and review, in-life data capture linked to treatments and groups, multi-parameter randomization, flexible task management and scheduling, and real-time data visualization from a centralized database to save time, reduce error, and increase collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Overwatch Research company profile →
NuGenesis
HQ: United States
Website
- Description: Provider of software for scientific data management systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGenesis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Jungla
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Jungla
2.2 - Growth funds investing in similar companies to Jungla
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Jungla
4.2 - Public trading comparable groups for Jungla
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →